Genome sequencing reveals driving mutations behind common brain tumor

| January 23, 2013
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The following is an excerpt.

Large-scale genomic sequencing has identified two DNA mutations that appear to drive about 15 percent of brain tumours known as meningiomas, a finding that could lead to the first effective drug treatments for the tumours, report scientists from Dana-Farber Cancer Institute and the Broad Institute.

View the original article here: Genomic Sequencing Reveals Mutant ‘Drivers’ of Common Brain Tumour

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend